PUMA SE: A Fixable Brand, but the Price Already Pays for Part of the Fix

The market is currently trading two narratives rather than current earnings. The first is Arthur Hoeld’s turnaround. The second is the strategic option created by ANTA Sports’ signed agreement to acquire Groupe Artémis’s 29.06% stake. Current-year earnings multiples contain little information because PUMA remains loss-making. The share instead trades on the probability that 2025 was the trough in brand economics, that 2026 can finish the cleanup, and that 2027 can reopen a profitable growth path.

The longer history explains why this is plausible without making it inevitable.

PUMA began in Herzogenaurach after the split between brothers Rudolf and Adolf Dassler. Rudolf registered his business in January 1948, operations began in June, the PUMA brand was registered in October, and the company adopted the PUMA name later that year. Its first durable franchise was genuine sports performance rather than fashion licensing: the Atom football boot arrived around 1950, followed by the Super Atom with screw-in studs in 1952, while PUMA running shoes were used in elite sprinting by the mid-1950s. That makes the company’s modern problem unusual. Performance authenticity is part of its origin story; management is now trying to restore commercial relevance by moving the business closer to that origin.

PUMA listed publicly in Germany in 1986. I found reliable company evidence for the listing year, but not sufficiently authoritative archival evidence for the original 1986 offer price and proceeds. I therefore do not manufacture an IPO valuation. That is one of this report’s explicit historical blind spots.

A later ownership phase placed PUMA inside the French luxury and consumer ecosystem around PPR/Kering. That period ended structurally in 2018 when Kering distributed most of its PUMA stake to its own shareholders, materially increasing PUMA’s free float; Groupe Artémis emerged with the large block that ANTA has now contracted to buy. PUMA subsequently entered a more conventional public-market chapter with greater free float, and a 10-for-1 forward stock split became effective in June 2019.

The operating high point came during the Bjørn Gulden era and the pandemic-era acceleration in athletic and casual footwear. PUMA called 2021 the best year in its history at the time: sales reached €6.805bn and EBIT €557.1m, an 8.2% margin. Sales then surged to €8.465bn in 2022. EBIT rose only to €640.6m, so operating margin slipped to 7.6%. Revenue reached €8.602bn in 2023 while EBIT fell to €621.6m and margin to 7.2%. Read the signature: the brand kept getting bigger after 2021, while each incremental euro of revenue created less operating profit.

By the end of 2023 the share was €50.52, down 10.8% during that year, with market capitalization around €7.6bn. Investors had begun to question whether scale growth was translating into brand quality and shareholder returns. In 2024 PUMA still presented growth and “brand elevation” as the path forward; on the then-reported basis, revenue was €8.817bn and EBIT roughly €622m. The later 2025 annual report restated 2024 continuing operations following classification of PUMA United as discontinued, leaving comparable continuing sales at about €8.398bn and EBIT at €548.7m, a 6.5% margin.

The 2025 break was larger than an ordinary bad footwear season. Continuing-operations sales fell to €7.296bn, gross margin dropped to 45.0%, adjusted EBIT became a €165.6m loss and reported EBIT a €357.2m loss. Free cash flow swung from positive €464.3m in 2024 to negative €530.3m. Inventory ended 2025 around €2.06bn, net debt rose above €1bn, and the board proposed no dividend for 2025 after paying €0.61 per share for 2024.

The share-price reset followed the earnings reset. One of the sharpest breaks occurred on July 25, 2025, when PUMA warned that annual sales would fall and that the company would generate a full-year loss; the shares opened roughly 18% lower. The vertical lesson: the market did not suddenly discover an unknown cyclical company. It withdrew the valuation attached to the idea that PUMA could keep taking global share while holding a mid- to high-single-digit EBIT margin.

Arthur Hoeld became CEO in July 2025 after a long career at adidas. In October he put a materially different diagnosis in front of investors. Management said PUMA had become too commercial, brand heat was muted, distribution quality was too low and much of the product offer was failing to cut through. The remedy: reduced exposure to mass merchants, lower promotional intensity, tighter product assortments, greater emphasis on full-price DTC and sharper investment behind Football, Running, Training and higher-quality Sportstyle.

The cost component is large. PUMA had already planned roughly 500 job reductions under its earlier “nextlevel” program; Hoeld added about 900 white-collar roles, bringing the total intended reduction to roughly 1,400 positions by the end of 2026. Management now describes the project as a three-year transformation, with 2025 as the reset, 2026 as the transition year and growth intended to resume from 2027.

One historical target needs to be handled carefully. The pre-Hoeld “nextlevel” plan had targeted an 8.5% EBIT margin by 2027. That target came from the previous strategic framework and is not the same thing as Hoeld’s current guidance. The new management team has spoken about restoring “healthy profits” and above-industry growth in the medium term without publicly recommitting to that precise 8.5% figure. I use 8.5% only as a historical reference point in valuation, never as current guidance.

That history supports the qualitative portrait: distressed turnaround. PUMA has proven over decades that it can create culturally important, technically credible sports products and distribute them globally. It has also proven over the past four years that global recognition alone does not protect full-price sell-through, margins or shelf space.

Financials, business model and moat

PUMA’s financial history since 2021 captures the entire investment argument in five lines. The apparent rise through 2023 was revenue-led; the collapse in 2025 exposed deterioration that had already been visible in margin and cash conversion.

† 2024 and 2025 reflect the continuing-operation presentation in the 2025 annual report where applicable; PUMA states that 2021–2023 were not retrospectively adjusted for the PUMA United discontinued operation, so the five-year series is directionally useful rather than perfectly like-for-like.

What sits behind the table matters more than the arithmetic. PUMA’s revenue expanded just over 26% from 2021 to 2023, yet EBIT increased only about 12%. The company was accepting weaker economics to keep volume moving. By 2025 that strategy collided with excess inventory, promotional wholesale, product misses and a consumer environment in which retailers had better alternatives. PUMA’s 2025 gross-margin decline was driven by inventory write-downs and wholesale promotional activity, partly offset by lower sourcing prices and a richer own-retail mix.

Revenue itself remains straightforward. PUMA designs and markets footwear, apparel and accessories, with manufacturing substantially sourced through external suppliers. Footwear is the largest category, and the one where running, football and lifestyle sneaker franchises matter most. Wholesale is still the biggest channel, even after DTC rose sharply as a share of sales. Licensing exists in categories such as eyewear and work/safety products, but royalty income is far too small to drive the investment case.

That leaves operating leverage running hard in both directions. Product cost and sourcing vary with volume, but marketing commitments, people, headquarters, IT, logistics infrastructure, leased stores and sponsorship assets do not fall at the same rate when sales decline. Adjusted operating expenses reached 48.5% of sales in 2025, up from 42.1% in restated 2024. PUMA spent about 2.2% of sales on research/product management, while depreciation and amortization reached €391.2m. A few hundred basis points of gross-margin repair thus carry enormous EBIT consequences once revenue stabilizes; the reverse remains equally true.

This is why management is attacking both denominator and numerator. Cutting 1,400 roles addresses the fixed-cost base. Reducing SKUs, promotional intensity and low-quality wholesale goes at gross margin and brand scarcity. Rebuilding high-performance categories is about revenue quality. Cutting only costs would improve accounting profit temporarily while making the brand weaker; cutting only distribution without compelling product would simply shrink sales. Hoeld’s plan has to do both.

The balance sheet moved from a source of comfort to an active part of the thesis. Cash from operations was a €319.3m outflow in 2025 after a €694.8m inflow in 2024, largely because changes in current assets consumed €429.2m. Fixed-asset investment was €206.3m. At year-end PUMA had €290m of cash and €1.202bn of unused credit lines, but net debt had risen to €1.064bn. Q2 2026 reduced the immediate pressure: cash was €372.5m, net debt €1.104bn and cash plus unused credit facilities totaled about €1.183bn. Liquidity is adequate for the present turnaround, but the company no longer has the capital-allocation freedom of a clean net-cash consumer franchise.

The dividend decision reflects that change. PUMA paid dividends while profitable and also bought back shares, but the 2025 loss resulted in a zero dividend proposal and management said it did not plan further treasury-share purchases in 2026. The balance-sheet priority is now deleveraging and inventory normalization. That is rational given the circumstances, although it also means the stock offers no dividend support while investors wait for the operating repair.

Cash-flow quality requires particular discipline. PUMA’s historical cash conversion was respectable in profitable years but highly working-capital sensitive. A reconstruction of the consolidated 2021–2025 period produces an aggregate operating-cash-flow/net-income ratio of roughly three times; that apparently strong number is distorted by the 2025 accounting loss and non-cash charges. Restricting the lens to profitable 2021–2024 produces a ratio nearer roughly 1.8 times, while 2025 then flips to negative operating cash flow. The underlying sources are PUMA’s annual cash-flow statements and comparative data, but the 2021 reconstruction and discontinued-operation presentation make false precision inappropriate.

The Q2 2026 cash result is equally easy to misread. Free cash flow of €328.8m came during a quarter when inventories, receivables and working capital were falling and capex was just €15.8m. PUMA explicitly expects a much larger share of the year’s roughly €200m capex in the second half. This is excellent evidence that the inventory reset is releasing cash. It is weak evidence for normalized earnings power.

PUMA does not disclose a maintenance-versus-growth capex split. For owner-earnings analysis I estimate €140m–€160m of the roughly €200m annual fixed-asset investment as maintenance of retail, IT and logistics, leaving around €40m–€60m as expansion or transformation investment. This is my modeling assumption, based on management’s description of where capex goes, not a company KPI. PUMA’s lease-heavy retail model adds a second economic reinvestment requirement: lease principal payments are financing cash flows under IFRS 16 and should not be ignored simply because the company’s reported FCF definition does not deduct them in the same way as ordinary capex. PUMA disclosed €208m of lease-principal repayments in 2023, illustrating the scale.

On the current 2025/2026 earnings run-rate, owner earnings are negative or too unstable for a meaningful P/E. In my base normalized case later in this report, a 6.5% EBIT margin produces roughly €350m–€380m of annual equity owner earnings after normal tax, interest, maintenance investment and lease economics. At today’s €4.01bn equity value that corresponds to roughly 11 times normalized owner earnings, or a normalized owner-earnings yield near 9%. That is a useful cross-check; it is not a current-year earnings multiple.

The moat has three pieces that still deserve credit.

First is global sports credibility. Football sponsorships, elite athletes and decades of performance product give PUMA permission to sell technical shoes and apparel at global scale. Running products around NITRO and Training through HYROX are providing fresh evidence that this credibility can still translate into product demand. Management reported strong sell-through for products including FAST-R and Deviate, while HYROX has supplied both participation culture and product exposure. This is more valuable evidence than celebrity impressions because it is tied to specific performance franchises.

Second is distribution and sourcing scale. PUMA remains large enough to serve global wholesalers, operate meaningful DTC infrastructure and source at volumes unavailable to a start-up. Scale contributed to lower sourcing costs in Q2 2026. The moat is weaker than Nike’s or adidas’s because those companies can spread product development, sports marketing and supply-chain investments over much larger revenue bases.

Third is an archive of recognizable products such as Suede and Speedcat. The archive has economic value only when management controls supply and connects old silhouettes to current taste. Speedcat’s recent momentum shows the upside; PUMA’s 2025 promotional intensity shows the downside. Archive recognition without full-price sell-through becomes a marketing moat rather than an economic moat.

PUMA’s central moat problem is weakened pricing power, not lack of awareness. In 2025 wholesale promotion and inventory write-downs drove gross margin down to 45.0%. In Q2 2026 headline margin recovered to 48.0%, but about 60 basis points came from tariff refunds. By contrast adidas produced a 52.5% Q2 gross margin and specifically cited healthy full-price selling, while On reported 64.2% in Q1 2026 and Deckers 56.4%. PUMA’s cultural visibility runs far ahead of its proven current pricing power.

Management deserves a medium credibility assessment rather than a high one. Hoeld’s diagnosis is unusually blunt and the early inventory/cost actions match it, but he has not yet delivered the hard part: renewed growth without reopening the discount channel. His long adidas background is relevant because adidas recently executed almost the exact operating arc PUMA now wants: cleaner inventories, stronger sell-through, rejuvenated footwear franchises and high-single-digit operating margins. PUMA has imported experience from that playbook. It has not yet imported the outcome.

Industry structure and horizontal competition

Sporting goods is a growing but mature consumer category whose economics are being redistributed rather than universally destroyed. McKinsey/WFSGI estimates that global industry growth averaged around 7% annually in 2021–2024 and could slow to about 6% in 2024–2029. Health awareness, sport participation and athletic clothing’s place in everyday wear remain structural demand supports. The same industry study flags intensifying competition and the rise of challenger brands.

The cycle is a mixture of consumer spending, fashion/product cycles and inventory cycles. A macro downturn can depress discretionary purchases. A footwear franchise cycle can overwhelm the macro picture: one company can grow double digits while another loses double digits because consumers suddenly want Samba, HOKA, Cloud or a new running foam system. PUMA currently sits in precisely that kind of relative product cycle.

The horizontal comparison makes that visible.

PUMA data are from its Q2 release; peer figures come from the companies’ latest available releases as of the base date. Nike’s Q4 gross margin was distorted upward by tariff-recovery accounting, so the table uses full-year margin instead.

Nike became the scale incumbent: global sport credibility, enormous athlete and league relationships, product R&D and distribution breadth. Its FY2026 revenue was flat reported and down 2% currency-neutral, with Direct down 8% and wholesale up 4%, showing that Nike itself is still repairing an earlier overemphasis on DTC and product concentration. Nike proves that incumbent sports brands can lose momentum without becoming obsolete. It also shows why PUMA cannot assume scale alone ensures recovery.

adidas is the most uncomfortable comparison. The companies share a home town, major categories, a European cost base and a wholesale/DTC model; Hoeld spent much of his career there. adidas went through a major inventory, product and distribution reset after 2022 and is now reporting record quarterly sales, 14% currency-neutral growth, 52.5% gross margin and 8.5% Q2 operating margin despite increasing marketing investment by more than €200m. H1 operating margin was 9.6%, and adidas raised its full-year revenue-growth outlook to 9%–10%.

Consumers are currently choosing adidas for a broad combination of renewed lifestyle heat and performance momentum. Its Q2 performance business grew 39%, led by Football and Running. That matters because PUMA’s stated priority categories are almost identical. adidas is executing better in the same arena, not merely occupying a different niche.

On became something different: a premium running-and-lifestyle challenger able to charge materially higher product prices while still growing. Q1 2026 sales rose 26.4% constant currency, DTC grew 28.7%, and gross margin reached 64.2%. Its economic advantage lies in product specificity and scarcity. A customer buying Cloudmonster or Cloudboom is often buying the product proposition itself rather than a generic sports logo. That translates into gross margin PUMA currently cannot approach.

Deckers’ HOKA franchise follows a related path. Deckers’ June 2026 quarter showed constant-currency growth of 4.8%, HOKA growth of 7.7%, DTC growth of 13%, a 56.4% gross margin and no outstanding borrowings. HOKA’s growth is slowing from its earlier pace, but the economic contrast with PUMA remains large: HOKA built share around a clear running proposition while PUMA spent much of the prior cycle trying to serve a much broader sports-and-lifestyle customer.

This is why On and HOKA are especially relevant to the “structural decline” argument. PUMA did not lose its ability to manufacture shoes. It lost consumer preference in parts of the market where specialty brands created stronger reasons to buy. A PUMA turnaround needs to reverse that at the product level; additional advertising by itself cannot.

Amer Sports provides a different comparison, centered on ANTA. Amer’s current portfolio includes Arc’teryx, Salomon, Wilson, Atomic and other specialized brands. Amer reported about 23% revenue CAGR from 2022 through 2025, a 58.0% adjusted gross margin, 17.5% adjusted EBITDA margin and roughly 49% DTC mix in 2025. ANTA was the key industrial shareholder behind the consortium that acquired Amer in 2019 and remains Amer’s largest shareholder after Amer returned to public markets in 2024. ANTA itself describes Amer as part of its multi-brand strategy.

The Amer analogy is valuable precisely because it breaks in several places.

Amer was a portfolio of brands with separate niches and substantial premium white space. Arc’teryx could grow technical luxury/outdoor apparel, Salomon could expand footwear, and Wilson could monetize racquet and ball sports. PUMA is one global mass-market brand competing head-on with Nike and adidas in football, running, training and lifestyle footwear. Amer’s portfolio structure allows capital to migrate toward the best franchise; PUMA’s corporate economics rise or fall with one master brand.

Ownership is also different. ANTA’s influence over Amer emerged from the controlling acquisition consortium. In PUMA, ANTA has signed for 29.06%. It can become a highly influential strategic shareholder, but 29% is not operating control.

That distinction limits what the “ANTA playbook” means. ANTA can contribute board-level pressure, knowledge of Chinese consumers, retail operations and relationships, and perhaps future cooperation in distribution or sourcing. ANTA has shown strong Chinese retail economics in its own portfolio: its 2025 H1 operating margin was 26.3%, e-commerce represented 34.8% of revenue and operating cash inflow was strong. Those capabilities are relevant. PUMA and ANTA have not announced a quantified revenue-synergy target, sourcing-savings target or integration plan. Any such number belongs to an analyst scenario, not the signed transaction.

The ecological niche PUMA should seek is clearer than its recent historical positioning. Nike owns extraordinary global sport scale; adidas currently combines global scale with lifestyle and performance heat; On and HOKA own focused premium performance territory. PUMA’s viable niche is a broad global challenger with credible Football and Running performance, selected culturally resonant Sportstyle and enough scale to underprice the premium specialists without becoming a discount substitute for Nike/adidas.

The most important horizontal evidence against structural decline is that PUMA still has product franchises that are selling; the strongest evidence for structural decline is that those wins have not yet been broad enough to offset a 9.4% group sales decline in a growing industry.

PUMA’s upstream model remains exposed to Asian manufacturing, freight, tariffs and currency. U.S. tariff changes moved gross margin visibly in Q2 2026, and geopolitical disruption in the Middle East was incorporated into the company’s updated assumptions. Management said the negative effect of the Middle East situation and favorable tariff-refund/lower-tariff effects were expected largely to offset in the full-year outlook. Tariffs are material, but product demand remains the larger long-term variable.

Current fundamentals, ANTA transaction and market narrative

The last twelve months can be read as a controlled descent followed by early stabilization.

In Q3 2025, sales fell 10.4% currency-adjusted. PUMA deliberately reduced wholesale exposure, took back or cleaned up product, restrained promotions and allowed inventory consequences to move through the P&L. DTC was still positive while wholesale declined sharply. Gross margin was only 45.2%, adjusted EBIT €39.5m and reported EBIT €29.4m. The operating message changed from “protect growth” to “accept lower sales to repair the marketplace.”

The full-year 2025 result then crystallized the cost. Sales were €7.296bn, reported EBIT negative €357.2m and FCF negative €530.3m. Inventory remained above €2bn and net debt exceeded €1bn. That was the financial trough from which 2026 guidance was established.

Q1 2026 supplied the first cleaner evidence. Currency-adjusted sales fell just 1.0%; gross margin improved 60 basis points to 47.7%; adjusted EBIT was positive €64.4m; inventory fell 8.6%; and FCF improved sharply year on year, although it was still a €201.4m outflow because of seasonality. Net debt stood at €1.358bn.

Q2 was more ambiguous:

PUMA Q1 and Q2 company disclosures.

H1 generated roughly €127m of free cash flow despite a reported operating result around break-even, largely because working capital began reversing. This is exactly what should happen in a competent inventory reset. Sales must eventually follow, because working capital can only be released once.

Management confirmed FY2026 guidance after Q2: low- to mid-single-digit currency-adjusted sales decline, reported EBIT loss between €50m and €150m, and capex around €200m. PUMA expects Q3 sales and EBIT to improve sequentially from Q2 and continues to describe 2027 as the point from which growth should return.

That guidance contains a high bar hidden inside a modest-looking number. H1 includes a weak Q2 and the full year is still expected to decline only low- to mid-single digits, so the second half has to show a better sales trajectory. The market will care far more about the exit rate into 2027 than whether reported 2026 EBIT lands at minus €80m rather than minus €110m.

The ANTA transaction changes the shareholder map without yet changing control.

ANTA announced on January 27 that it had entered a share purchase agreement with Groupe Artémis to acquire 43,014,760 PUMA shares, or 29.06%, at €35 per share. The exact contractual consideration is about €1.506bn and is to be funded from ANTA’s internal cash resources. After settlement ANTA intends to seek appropriate representation on PUMA’s Supervisory Board, while preserving PUMA’s status and governance as an independently managed German-listed company.

As of the August 9 research base date, the transaction should be described as signed, not completed. ANTA’s public materials continue to state that closing is expected by the end of 2026 subject to regulatory conditions, and I find no public completion announcement. ANTA obtained written shareholder approval in February; the HKEX record subsequently published the major-transaction circular in April.

The SPA lists competition clearances, PRC National Development and Reform Commission approval and relevant foreign-investment approvals among the conditions precedent. The publicly available disclosures I reviewed do not provide a regulator-by-regulator table stating that every required clearance has been received. I therefore treat regulatory clearance as pending unless and until ANTA files otherwise. The agreement provides a December 31, 2026 long-stop mechanism; if the conditions are not met by then, the existing SPA can terminate absent an amendment.

ANTA said at announcement that it had no plan for a full takeover. I found no subsequent public statement reversing that position by the research date. The transaction documentation nevertheless contains provisions dealing with circumstances such as a later takeover, delisting, squeeze-out or competing offer during a defined post-transfer period. Those contractual provisions preserve optionality; they do not constitute an announced intention to buy the rest of PUMA.

German takeover law sets “control” for mandatory-offer purposes at 30% of voting rights. A 29.06% holding sits below that threshold, assuming ANTA is not attributed additional voting rights through acting-in-concert or other attribution rules. That leaves the stake short of automatically triggering a mandatory offer for all PUMA shares.

At 29.06%, ANTA can become an influential owner; it cannot simply run PUMA. Supervisory Board representation can give ANTA a voice in CEO oversight, long-range strategy and major capital-allocation decisions. Its shareholder vote will matter substantially at general meetings. China expertise can facilitate commercial cooperation. The Management Board retains responsibility for day-to-day product, pricing, sourcing and marketing, and ANTA cannot unilaterally impose a China distribution model or sourcing consolidation simply because it owns 29%.

The most measurable potential benefit is China. From PUMA’s 2025 disclosures, Greater China sales were roughly €489m, derived from disclosed regional gross profit of €246.3m at a 50.4% gross margin, about 6.7% of group sales. If PUMA eventually restored group sales to €8.2bn and Greater China reached 9%–10% of sales, China would generate about €740m–€820m, or roughly €250m–€330m above the 2025 level. That is my scenario, not guidance from either company.

I give no explicit ANTA sourcing synergy to the base valuation. The bull scenario allows roughly 50 basis points of potential margin benefit from a combination of sourcing, retail knowledge and China mix, but no public source currently justifies a higher number. This is deliberate: the value of ANTA’s involvement should first be proven in operational disclosures.

The downside from a failed transaction is mostly strategic and narrative rather than a direct cash loss to PUMA. The purchase consideration is paid by ANTA to Artémis, not into PUMA. PUMA would therefore not lose €1.5bn of corporate funding if approval failed; it would lose a prospective long-term shareholder, board influence and China/retail optionality. Any termination payment under the SPA is an issue between the contracting buyer and seller rather than cash available to PUMA.

Price behavior gives a rough sense of how much optionality investors are attaching to all this. PUMA closed at €21.63 immediately before the ANTA announcement. ANTA agreed to pay €35 for Artémis’s strategic block, a 62% premium to that unaffected close; PUMA shares initially rose as much as roughly 17% and were still up around 6% during the morning of the announcement. The stock stood at €27.11 on August 7, 25.3% above the unaffected January price but still 22.5% below the €35 strategic-block price.

The €35 price is not a takeover floor. ANTA is purchasing an influential 29% block from one seller and may attach strategic value to board influence and globalization. Public minority shareholders have no contractual right to sell to ANTA at €35.

My event-based attribution of the roughly 25 percentage-point rise from January 26 through August 7 is approximately 7–10 points from the transaction announcement itself, 10–14 points from PUMA-specific turnaround evidence and 3–6 points from the broader improvement in sportswear/challenger sentiment. These are analytical estimates, not observable accounting facts. The deal window provides the first bucket directly; the later split is inferred from PUMA’s Q1/Q2 inventory and cash improvements alongside very strong adidas results, positive On/Deckers growth and still-weak Nike topline trends.

The Q2 price reaction shows that investors are already demanding evidence beyond cost and cash cleanup. PUMA shares fell as much as 7% on July 31 after management confirmed rather than raised guidance, despite a narrower-than-expected reported operating loss. Xetra-market historical data put the July 30 price around €28.20 and August 7 at €27.11, a decline of roughly 3.9% around and after the print.

I attribute almost all of that post-Q2 decline to a PUMA-specific turnaround-expectation revision: investors saw -9.4% sales and no guidance upgrade. Deal status did not materially change. Sector news was arguably supportive because adidas had just reported record quarterly sales and raised its top-line outlook. The point is worth isolating: the market is no longer giving PUMA a free pass merely for shrinking inventory.

The bull case today rests on four pieces of evidence: gross margin and inventory are moving in the intended direction; Running and Training have specific products with positive sell-through; restructuring will reduce a substantial fixed-cost burden; and ANTA is willing to commit €1.5bn at €35 a share for a strategic stake.

The bear case rests on equally concrete evidence: PUMA is shrinking while its industry grows; adidas is expanding 14% currency-neutral almost next door; wholesale is falling far faster than DTC is growing; headline Q2 gross-margin and FCF improvements contain tariff-refund, working-capital and capex-timing benefits; and current management has yet to show a quarter of renewed group growth.

Valuation, risks and tracking framework

Current-year P/E is the wrong tool for PUMA. FY2025 reported EBIT was negative €357.2m and FY2026 guidance still calls for a reported operating loss of €50m–€150m. Applying a “normal” P/E to a negative denominator says nothing about the business’s recoverable earning power.

My primary method is a mid-cycle EBIT-margin-and-enterprise-value bridge, cross-checked against EV/Sales and normalized owner earnings. It fits PUMA because the key unknown is not whether the company can report a few cents more or less of EPS in 2026; it is the EBIT margin the brand can support after the cleanup.

The margin assumptions are deliberately anchored to history and peers. PUMA produced 6.5%–8.2% EBIT margins through the 2021–2024 period before the 2025 collapse. The former management plan once targeted 8.5% by 2027, though that target is no longer current guidance. adidas is already at a 9.6% H1 2026 margin. Against that, I use 5.0% as a conservative recovered PUMA margin, 6.5% in the base case and 8.0% in the optimistic case.

Current enterprise value is about €5.12bn using the August 7 market capitalization of approximately €4.01bn and June 30 net debt of €1.104bn. Against 2025 sales of €7.296bn, that is about 0.70 times EV/Sales. Against a roughly €6.9bn–€7.0bn 2026 sales level implied by the present guidance range, it is about 0.73–0.74 times.

Historically, this is a distressed valuation. Around PUMA’s 2021 operating peak, an above-€100 share price against €6.8bn of sales implied a sales valuation several times today’s level; by year-end 2023 the equity value had already fallen to around €7.6bn against €8.6bn of annual sales. I would describe the current EV/Sales valuation as roughly bottom-quintile territory within the post-2018 period, although I have not reconstructed a daily enterprise-value series precise enough to claim an exact percentile.

The ANTA price provides another cross-check. €35 applied to all roughly 148m shares would imply equity value around €5.18bn; adding current net debt gives enterprise value around €6.28bn, equivalent to roughly 0.86 times 2025 sales. That is meaningfully above the market’s current 0.70 times, yet nowhere near the sales multiples associated with a high-growth premium footwear company. The strategic buyer is paying for recoverability, not for a business that is already repaired.

The peer valuation gap is economically justified even without forcing incomparable P/E ratios into a table. On and Deckers deserve higher sales multiples because they combine positive growth, materially higher gross margins and positive earnings. adidas merits a higher multiple than PUMA while it is growing double digits at near-10% operating margins. PUMA’s discount can narrow only when its margin and sales trajectory converge toward those economics.

The absolute scenarios are as follows. Values are present values as of the research date; the terminal operating year is 2029, approximately 3.4 years away.

The conservative scenario assumes that PUMA repairs inventory and costs but never regains industry-level growth: 2029 revenue is still below the pre-crisis 2024 continuing-operations level, and the brand earns only a 5% margin. The base case restores PUMA approximately to the low end of its pre-crisis profitability while keeping revenue below the level a 6%-growing industry would imply. The optimistic case requires broad product recovery, improved wholesale productivity, strong China execution and margins close to the 2021 peak. Historic PUMA margins, current guidance and peer operating performance provide the anchors; the scenario revenue, multiples, debt and discount rates are my assumptions.

In owner-earnings terms, the base case produces roughly €350m–€380m of sustainable annual equity cash earnings after allowing for normalized tax, interest, maintenance capex and lease economics. The resulting normalized owner-earnings yield at today’s market capitalization is around 9%, against a current headline P/E that is meaningless because the denominator is negative. Owner economics, not current accounting earnings, govern my valuation judgment.

This is valuation-scenario analysis within a research framework, not investment advice.

The expectation gap is concentrated in 2027. At €27.11 the market does not require an 8% margin, because the stock remains far below the optimistic valuation. It does require substantially more than simple survival. The current price sits roughly two-thirds of the way from my conservative value to my base value and only modestly above the lower edge of the base hold zone. In practical terms, investors are pricing a reasonable probability that PUMA gets back to mid-single-digit profitability.

The next major earnings event is scheduled for October 30, 2026, according to PUMA’s financial calendar. Three pieces of information will matter far more than quarterly EPS: whether the sales decline is narrowing sequentially, whether gross margin stays near or above 48% after stripping tariff refunds, and whether inventory continues to fall without wholesale orders deteriorating again.

The most fragile assumption in my base case is the 6.5% normalized EBIT margin. Cutting that assumption to 70%, or 4.55%, while leaving base revenue and the terminal multiple unchanged reduces present value from €31.1 to about €21.2 per share. The model therefore has high operating-margin convexity. That is exactly what a turnaround stock should have, and exactly why a superficially low EV/Sales multiple should not be mistaken for a margin of safety.

The flat-earnings test cuts deeper. If PUMA simply remains around the present loss/near-break-even earnings level for three years, pays no dividend and the share price does not re-rate, the shareholder’s annualized return is approximately 0%. Germany’s benchmark 10-year government yield was about 3.1% on August 7. Under that test, there is no margin of safety at this buy price.

Margin-of-safety sufficiency verdict: not obvious. The current €27.11 price is a substantial premium to the €18.3 conservative value, so the conservative scenario itself offers no downside cushion. The stock becomes compelling only at a price that allows the turnaround to be partly wrong.

The risks that could create permanent rather than temporary loss are specific.

The highest-probability, high-impact risk is persistent brand-share loss. The observable signal is PUMA remaining negative in currency-adjusted sales through 2027 while adidas, On, HOKA and the industry remain positive. The transmission path runs from weaker wholesale orders to more aged inventory, deeper discounts, gross margin below 46%–47%, lower EBIT and eventually a distressed EV/Sales multiple. adidas’s current 14% growth versus PUMA’s -9.4% shows this is already an active risk rather than a theoretical one.

A medium-probability, high-impact risk is that cash improvement proves mainly a working-capital harvest. Inventory can fall once and receivables can fall once. If 2027 sales remain weak, free cash flow loses that tailwind while marketing and product investment must continue. Net debt could then remain above €1bn or rise again. Watch FCF after working-capital normalization, not the Q2 headline alone.

A low-to-medium-probability, medium-to-high-impact risk is ANTA transaction failure or prolonged regulatory delay. The direct PUMA cash effect is small because PUMA is not receiving the consideration. The valuation effect could be much larger if investors remove China/ownership optionality at the same time operating results disappoint. The December 31 contractual long-stop makes year-end a natural event boundary.

Tariff and geopolitical risk is medium probability and medium impact. Q2 showed that tariffs can shift quarterly gross margin by tens of basis points, while the Middle East situation has already entered management’s guidance calculus. It becomes a permanent-loss risk only if PUMA lacks pricing power to pass through structurally higher landed costs while competitors can.

The final high-impact risk is execution under cost reduction. PUMA intends to remove around 1,400 corporate positions while simultaneously improving product creation, marketing, wholesale relationships and DTC. Cutting administration is helpful; cutting the people or capabilities that create the next NITRO or Speedcat would turn a turnaround program into brand harvesting.

Positive catalysts over the next twelve months are narrowing sales declines in Q3 and Q4, gross margin holding around 48% without unusual tariff benefits, continued inventory decline, net debt below €1bn, stronger wholesale bookings for 2027, broader Running/Training momentum, and regulatory progress on ANTA. Negative catalysts are another guidance cut, a return to inventory growth, gross margin falling below 46.5%, continued double-digit wholesale contraction, weaker product sell-through or transaction termination.

The dashboard I would actually use is narrow:

The first four indicators decide whether PUMA is restoring economic demand rather than merely shrinking itself. Inventory and net debt tell us whether the reset is financially controlled. Wholesale is the hardest commercial test because a global sports brand cannot replace all third-party distribution with its own stores without sacrificing reach and capital efficiency. China provides the earliest market in which ANTA-linked knowledge could become visible, although any attribution to ANTA should wait until the transaction closes. The next-results date is from PUMA’s current investor calendar.

Cross-synthesis and final research conclusion

Looking vertically, PUMA’s proven capability is reinvention around sport and style. It began as a performance-footwear company, survived multiple ownership regimes, expanded into a global multi-category brand and reached record scale in the early 2020s. That history rules out the simplest bear narrative that PUMA is an empty logo. The company has real sports heritage, a global wholesale network, credible athlete relationships, product development capabilities and archival footwear with recurring cultural relevance.

Past success was nevertheless more dependent on favorable product and distribution cycles than the peak valuation implied. From 2021 through 2023, sales grew much faster than EBIT. Management tolerated a lower margin in exchange for scale, and DTC investment added fixed cost while wholesale remained crucial. When product momentum weakened and inventories rose, maintaining distribution required more promotion. The deterioration started before 2025’s reported loss. 2025 made the accumulated weakness impossible to ignore.

That distinction matters for the fixable-versus-structural question. Structural decline would mean PUMA’s basic consumer proposition has stopped working: products cannot command full price, wholesale customers permanently reallocate shelf space and no meaningful category generates organic demand. The evidence has not reached that point. Running and Training show genuine product-level sell-through, Speedcat remains relevant, China DTC is growing, gross margin is recovering and inventory is moving down at a double-digit rate.

The evidence also does not support declaring the turnaround proven. Group sales are down 9.4% in the latest quarter. Wholesale is down 14%. adidas is up 14% and its performance business up 39%. On remains above 20% constant-currency growth. Deckers remains profitable with a mid-teens operating margin. A growing industry is currently distributing demand away from PUMA faster than PUMA is recovering it.

That leads me to a specific view of what is temporary and what is structural. Excess inventory, mass-merchant exposure, excessive SKUs, parts of the overhead base and some wholesale discounting are fixable. PUMA’s relative lack of pricing power versus adidas, On and HOKA is structural until product execution changes it. Management cannot cost-cut its way out of the latter.

The encouraging part of Hoeld’s plan is that it acknowledges this. Management is intentionally taking low-quality sales out of the system, which explains some current revenue weakness. It is reducing promotions rather than chasing volume, and is concentrating resources in fewer categories. The difficult part is timing: competitors do not pause while PUMA fixes itself. Every season of negative sell-through gives retailers another reason to shift open-to-buy dollars elsewhere.

The ANTA transaction improves the distribution of possible outcomes but does not solve the operating problem. A shareholder with ANTA’s Chinese retail experience, capital base and history with Amer is more useful than a passive financial owner. Board representation can increase accountability. China is underdeveloped enough to offer measurable white space. Yet the economic value remains optionality until the deal closes and collaboration is actually implemented.

Amer is the reason to take ANTA seriously and the reason to resist easy extrapolation. Amer’s premium specialized brands had clear geographical and category white space, and ANTA participated through a control-oriented consortium. PUMA is already a global mass brand operating directly against two giants and a crowd of faster challengers. A 29% shareholder cannot transplant Amer’s economics into PUMA by decree.

The market appears to understand some of this. At €27.11, PUMA is 25% above the unaffected pre-ANTA price but still 22.5% below ANTA’s €35 strategic purchase price. That is a sensible shape for the uncertainty: the stock recognizes the strategic shareholder and early turnaround progress while refusing to treat €35 as an offer to public shareholders.

The price also explains why “fixable company” does not automatically equal “cheap stock.” My conservative recovered value is only €18.3. My base value is €31.1. The present price already requires a meaningful probability of rebuilding a 6%-plus margin. A buyer today is underwriting execution, not merely buying liquidation value.

The next year is mainly about proof of stabilization. I want to see Q3/Q4 sales declines narrow, gross margin around 48% without one-off tariff assistance, inventory remain down and year-end net debt fall. A single quarter of positive sales would help; broad wholesale stabilization would matter more.

The three-year variable is normalized margin. At a 4%–5% margin PUMA is a lower-quality global sports brand whose appropriate enterprise-value multiple remains constrained. At 6%–7%, today’s equity starts to look reasonable because the cost base has recovered and the brand has regained economic relevance. Around 8%, the bull valuation becomes plausible because PUMA would again be earning close to its historical peak economics.

The five-year variable is brand position. Investors should stop thinking in terms of “turnaround” by then. Either PUMA will have become a profitable global challenger with a clearer performance/lifestyle identity, or it will have settled into a structurally weaker tier whose cultural awareness exceeds its ability to earn a return on that awareness.

My settled answer is: PUMA is probably fixable, but the equity market is already charging investors for part of the fix. I would overturn the “fixable” diagnosis if, after the distribution reset is substantially finished, group currency-adjusted sales remain negative through 2027 while gross margin falls back below roughly 46.5%–47%, or if Running/Training wins fail to broaden into wholesale reorder growth. Conversely, two consecutive quarters of positive group growth with gross margin at or above 48%, continued inventory discipline and a clear path toward a 5%+ EBIT margin would materially raise confidence.

Bull reasons:

• Q2 inventory fell 15.3% and gross margin rose to 48.0%, evidence that the excess-product reset is moving in the intended direction.
• Running, Training and Speedcat provide specific product-level evidence that consumers have not rejected the PUMA brand across the board.
• Roughly 1,400 planned corporate-role reductions plus SKU and distribution rationalization create substantial operating leverage if sales stabilize.
• ANTA is contractually willing to pay €35 per share for a 29.06% strategic block and seek Supervisory Board representation, validating some long-term strategic value above the unaffected market price.

Bear reasons:

• Latest currency-adjusted sales are down 9.4% while the sporting-goods industry is structurally growing and adidas is expanding 14%, evidence of company-specific share loss.
• Wholesale fell 14% in Q2, showing the cleanup is also costing PUMA distribution volume and shelf demand.
• Q2’s 48% gross margin includes roughly 60 basis points of tariff refunds, while the €329m FCF figure benefited from working-capital release and low quarterly capex.
• PUMA has produced two loss-making years at the reported operating level across 2025 and guided 2026, net debt remains above €1bn, and the dividend has disappeared.
• The ANTA transaction is not closed, provides no cash to PUMA and gives a 29% investor influence rather than control; no quantified operating synergies have been announced.

Pre-mortem, first script: by mid-2027 adidas continues double-digit growth in Football and Running while HOKA and On retain specialist-running share. Speedcat rolls out of fashion before Suede or another Sportstyle platform replaces it. PUMA’s group sales decline another 3% in 2027, wholesale remains down high single digits and management reopens promotions to clear product. Gross margin falls to 45%, normalized EBIT margin reaches only 1%–2%, and net debt remains near €1bn. The market values the business at roughly 0.4–0.5 times sales rather than 0.7 times. On sales around €7bn, that would support equity in roughly the €12–€16 area after debt, a 40%–55% loss from €27.11.

Second script: regulatory conditions remain unresolved into December, the ANTA SPA terminates or is materially delayed, and China wholesale customers remain cautious. At the same time PUMA misses its promised 2027 growth inflection. The strategic-option premium unwinds from the share price, €35 ceases to function even psychologically as a reference point, and the market moves toward my conservative standalone valuation around €18. A simultaneous margin disappointment could push the share closer to the mid-teens. The key feature of this scenario is interaction: transaction failure alone need not halve the stock; transaction failure plus evidence of structural brand erosion can.

Final research conclusion:

PUMA is a globally relevant brand whose financial failure in 2025 was the endpoint of several years of declining incremental economics rather than a random one-year shock. Hoeld’s reset is addressing the correct problems: inventory, distribution quality, discounts, SKU complexity, fixed cost and lack of focus. The first measurable proof is visible in inventory and gross margin. Demand proof is still incomplete. The most direct competitor, adidas, is showing that a sportswear turnaround can work and simultaneously raising the performance standard PUMA must meet.

At €27.11, I would distinguish owning from initiating. An existing shareholder is being paid with substantial upside if PUMA returns to a 6.5%–8% margin, while the current valuation is low relative to the company’s old peak. A fresh buyer has only a weak margin of safety because the conservative normalized value is about €18. The stock becomes materially more asymmetric below €15, where an investor could be wrong about much of the turnaround and still have paid well below conservative recovered value. The alternative route to becoming more attractive is operational rather than price-based: sustained positive sales, 48%+ clean gross margin and visible progress toward a mid-single-digit EBIT margin would justify raising the conservative case.

【Company-profile scores】

• Fundamental quality: medium
• Growth: low
• Moat: medium
• Financial soundness: medium
• Management credibility: medium
• Valuation attractiveness: medium
• Risk level: high
• Suitable investor type: event-driven

【Investment rating】

• Rating: Hold
• One-line thesis: Inventory and margin repair are real, but €27 already assumes meaningful recovery before PUMA has proven renewed sales growth.
• Ideal buy price: €14.0–€14.5, at least 20% below the €18.3 value implied by the conservative normalized-margin scenario.
• Acceptable hold price: €26.5–€35.5, approximately ±15% around the €31.1 base value.
• Clearly overvalued price: €55.5 and above, more than 10% above the €50.3 optimistic present value.
• Current-price classification: acceptable hold.
• Whether to wait for a better price: yes. For new money, I would wait for €14.0–€14.5 without stronger operating evidence, or accept a higher entry only after positive group growth, gross margin of at least 48% excluding material one-offs, and a credible path to a 5%+ EBIT margin. The opportunity cost is missing a deal/turnaround re-rating if ANTA closes and 2027 orders improve before the stock revisits the buy zone.
• Target holding horizon: 3–5 years.
• Expected annualized return: conservative approximately -2.5%; base approximately +14%; optimistic approximately +31%, using the modeled 2029 terminal equity values and excluding dividends.
• Max-loss risk: approximately 40%–55% in the pre-mortem case where 2027 growth fails, gross margin returns to about 45%, EBIT margin remains 1%–2%, net debt stays near €1bn and the sales multiple compresses to roughly 0.4–0.5 times.
• Reassessment-trigger signals: two consecutive quarters below 46.5% gross margin; currency-adjusted sales still negative through 2027 while the industry remains positive; inventory returning to more than 5% year-on-year growth; net debt above €1.3bn after the 2026 reset; or termination of the ANTA transaction combined with no improvement in China/wholesale demand.

【Ideal Buy Price】14.0–14.5 EUR Basis: at least a 20% discount to the €18.3 conservative present value, which assumes €7.6bn 2029 revenue, 5.0% normalized EBIT margin and 11.0x EV/EBIT.

【Valuation Range】

• current: 27.11 (close as of 2026-08-07)
• bear (conservative · ideal buy zone): [14.0, 14.5]
• base (fair · acceptable hold zone): [26.5, 35.5]
• bull (optimistic · above the clearly-overvalued line): [55.5, 60.0]

Research uncertainties and source discipline: five blind spots deserve explicit treatment. First, neither ANTA nor PUMA has published a regulator-by-regulator clearance ledger for the 29.06% transaction, so I refuse to infer individual approvals from silence. Second, PUMA does not disclose channel gross margins, full-price sell-through or discount depth in enough detail to test pricing power directly; gross-margin trends, inventory and management commentary are proxies. Third, maintenance versus growth capex is not disclosed, so the owner-earnings split in this report is an analyst estimate. Fourth, I could verify the 1986 listing but not a sufficiently authoritative original IPO offer price and proceeds. Fifth, the in-house sibling reports named in the brief were not supplied as retrievable documents in this research session; I therefore cannot honestly claim line-by-line consistency with 02020-2026-08-07, as-2026-08-08, onon-2026-06-17 or the other internal reports. Public-company primary disclosures were used independently instead.

The primary source base is PUMA’s 2025 Annual Report, Q1 and Q2 2026 releases, H1 report and Q2 earnings transcript; PUMA’s October 2025 strategy disclosure; ANTA’s HKEX transaction documentation and corporate release; BaFin material on Germany’s takeover threshold; and the latest primary results from adidas, Nike, On, Deckers, ANTA and Amer. Reuters is used principally for contemporaneous market reaction and deal reporting, and McKinsey/WFSGI for the industry-growth frame.

Other tickers mentioned

• 2020.HK — ANTA Sports is the signed buyer of Groupe Artémis’s 29.06% PUMA stake and the prospective strategic shareholder.
• AS.US — Amer Sports is the most relevant precedent for ANTA’s ability to develop Western sporting-goods assets, while differing materially in brand portfolio and control.
• ADS.XETRA — adidas is PUMA’s closest structural comparator and currently provides the clearest benchmark for a successful sportswear inventory, product and margin reset.
• NKE.US — Nike is the global scale incumbent and another large brand undergoing a distribution and product-cycle repair.
• ONON.US — On is a premium running challenger whose growth and gross margin illustrate share PUMA has lost to specialized propositions.
• DECK.US — Deckers, through HOKA, provides the second major challenger-brand benchmark in running footwear.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.